- Home
- CUK vs ONC Comparison
CUK vs ONC Comparison
Compare CUK & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUK
- ONC
- Stock Information
- Founded
- CUK 1972
- ONC 2010
- Country
- CUK United States
- ONC Switzerland
- Employees
- CUK 87000
- ONC N/A
- Industry
- CUK Marine Transportation
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- CUK Consumer Discretionary
- ONC Health Care
- Exchange
- CUK Nasdaq
- ONC Nasdaq
- Market Cap
- CUK 26.6B
- ONC 26.9B
- IPO Year
- CUK 2000
- ONC N/A
- Fundamental
- Price
- CUK $21.43
- ONC $247.08
- Analyst Decision
- CUK Buy
- ONC Strong Buy
- Analyst Count
- CUK 17
- ONC 7
- Target Price
- CUK $26.76
- ONC $326.43
- AVG Volume (30 Days)
- CUK 2.0M
- ONC 314.8K
- Earning Date
- CUK 06-24-2025
- ONC 08-06-2025
- Dividend Yield
- CUK N/A
- ONC N/A
- EPS Growth
- CUK 377.81
- ONC N/A
- EPS
- CUK 1.52
- ONC N/A
- Revenue
- CUK $25,424,000,000.00
- ONC $4,175,868,000.00
- Revenue This Year
- CUK $7.03
- ONC $869.15
- Revenue Next Year
- CUK $3.43
- ONC $19.07
- P/E Ratio
- CUK $14.94
- ONC N/A
- Revenue Growth
- CUK 12.66
- ONC 51.16
- 52 Week Low
- CUK $12.65
- ONC $141.31
- 52 Week High
- CUK $26.14
- ONC $287.88
- Technical
- Relative Strength Index (RSI)
- CUK 56.36
- ONC N/A
- Support Level
- CUK $20.05
- ONC N/A
- Resistance Level
- CUK $21.62
- ONC N/A
- Average True Range (ATR)
- CUK 0.50
- ONC 0.00
- MACD
- CUK -0.15
- ONC 0.00
- Stochastic Oscillator
- CUK 61.94
- ONC 0.00
About CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service at the end of fiscal 2024. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.